Editorial Commentary
Publish Ahead of Print
The articles on this page have been copyedited and reviewed and approved by the authors. They have not yet been scheduled for a specific issue. For published content, please visit Archive.
Original Article
Efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer: a real-world, multicenter, retrospective study
Editorial Commentary
Subcutaneous delivery of immune checkpoint inhibitors: new route replacing intravenous administration?
Editorial Commentary
Antibody-drug conjugate development: opening windows for EGFR-mutant EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancers?
Editorial Commentary